Atlas Trials

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Clinical trial NCT01474161 · COMPLETED

Trial details

NCT number
NCT01474161
Sponsor
Genfit
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 DiabetesDiabetes Mellitus, Type 2Metabolic DiseasesCardiovascular DiseasesObeseDyslipidemia
Start date
2011-11-01
Primary completion
2012-11-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.